MAPT and early-onset autosomal dominant Alzheimer disease: Pathological traits available for these brain tissues included levels of global Aβ neuritic plaque and tau NFT deposition as measured by the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) criteria and the Braak staging system, respectively [28, 29].